Listed

AtriCure, Inc.

ATRCNasdaqCIK 1323885HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$153.6mRevenue, Q2 FY2026, three months to 2026-06-30$153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 27, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$153.6mRevenue, Q2 FY2026, three months to 2026-06-30$153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure+12.8% on a year earlier
  • Gross margin77.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $118.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure+2.7 pts on a year earlier
  • Operating margin6.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure+10.8 pts on a year earlier
  • Net margin5.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure+10.4 pts on a year earlier
  • Diluted EPS$0.18Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figureSign changed from a year earlier
  • Free cash flow$18.4mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-27, accession 0001323885-26-000035. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-27, accession 0001323885-26-000035. Derived: 6-month figure less the 3-month figure.Report this figure−2.8% on a year earlier

Last eight quarters

Full statements
Revenue$153.6mGross margin 77.2%
Diluted EPS$0.18, Q2 FY2026
Free cash flow$18.4m, Q2 FY2026
AtriCure, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m116Revenue, Q3 FY2024, three months to 2024-09-30$115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure124Revenue, Q4 FY2024, three months to 2024-12-31$124.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure124Revenue, Q1 FY2025, three months to 2025-03-31$123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure136Revenue, Q2 FY2025, three months to 2025-06-30$136.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure134Revenue, Q3 FY2025, three months to 2025-09-30$134.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure141Revenue, Q4 FY2025, three months to 2025-12-31$140.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure141Revenue, Q1 FY2026, three months to 2026-03-31$141.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure154Revenue, Q2 FY2026, three months to 2026-06-30$153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure
Gross margin%74.9%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $86.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Revenue: $115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure74.5%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $92.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Revenue: $124.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure74.9%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $92.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Revenue: $123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure74.5%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $101.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $136.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure75.5%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $101.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Revenue: $134.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure75.0%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $105.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Revenue: $140.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure77.4%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $109.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Revenue: $141.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure77.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $118.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure
Operating margin%(6.4%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Revenue: $115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure(11.7%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$14.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Revenue: $124.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(4.8%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Revenue: $123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure(4.5%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $136.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure0.2%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $208.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Revenue: $134.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure1.8%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Revenue: $140.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.4%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $526.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Revenue: $141.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure6.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure
Net margin%(6.8%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Revenue: $115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure(12.5%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Revenue: $124.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(5.5%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Revenue: $123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure(4.5%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $136.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure(0.2%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$267.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Revenue: $134.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figure1.2%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Revenue: $140.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure0.1%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $108.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Revenue: $141.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure5.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure
Diluted EPS$ per share(0.17)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figurenot reported (Diluted EPS not reported)(0.14)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure(0.13)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure(0.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001323885-25-000103.Report this figurenot reported (Diluted EPS not reported)0.00Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure0.18Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-27, accession 0001323885-26-000035.Report this figure
Free cash flow$m16.4Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001323885-25-000103. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001323885-25-000103. Derived: 9-month figure less the 6-month figure.Report this figure3.1Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(13.2)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Capital expenditure: $2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure19.0Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-27, accession 0001323885-26-000035. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-27, accession 0001323885-26-000035. Derived: 6-month figure less the 3-month figure.Report this figure24.1Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $26.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001323885-25-000103. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001323885-25-000103. Derived: 9-month figure less the 6-month figure.Report this figure18.4Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001323885-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(7.8)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Capital expenditure: $3.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001323885-26-000023.Report this figure18.4Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-27, accession 0001323885-26-000035. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-27, accession 0001323885-26-000035. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$534.5mGross margin 75.0%
Diluted EPS−$0.24, FY2025
Free cash flow$48.3m, FY2025
AtriCure, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m274Revenue, FY2021, twelve months to 2021-12-31$274.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-16, accession 0001323885-24-000016.Report this figure330Revenue, FY2022, twelve months to 2022-12-31$330.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0001323885-25-000009.Report this figure399Revenue, FY2023, twelve months to 2023-12-31$399.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure465Revenue, FY2024, twelve months to 2024-12-31$465.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure535Revenue, FY2025, twelve months to 2025-12-31$534.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure
Gross margin%75.0%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $205.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-16, accession 0001323885-24-000016.Revenue: $274.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-16, accession 0001323885-24-000016.Report this figure74.4%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $245.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-14, accession 0001323885-25-000009.Revenue: $330.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0001323885-25-000009.Report this figure75.2%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $300.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $399.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure74.7%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $347.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $465.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure75.0%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $400.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $534.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure
Operating margin%20.1%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $55.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-16, accession 0001323885-24-000016.Revenue: $274.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-16, accession 0001323885-24-000016.Report this figure(12.9%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$42.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-14, accession 0001323885-25-000009.Revenue: $330.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0001323885-25-000009.Report this figure(6.7%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $399.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure(8.6%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$40.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $465.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure(1.8%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$9.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $534.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure
Net margin%18.3%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $50.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-16, accession 0001323885-24-000016.Revenue: $274.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-16, accession 0001323885-24-000016.Report this figure(14.1%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$46.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-14, accession 0001323885-25-000009.Revenue: $330.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-14, accession 0001323885-25-000009.Report this figure(7.6%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$30.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $399.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure(9.6%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$44.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $465.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure(2.1%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001323885-26-000007.Revenue: $534.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure
Diluted EPS$ per share1.09Diluted EPS, FY2021, twelve months to 2021-12-31$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-16, accession 0001323885-24-000016.Report this figure(1.02)Diluted EPS, FY2022, twelve months to 2022-12-31−$1.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-14, accession 0001323885-25-000009.Report this figure(0.66)Diluted EPS, FY2023, twelve months to 2023-12-31−$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure(0.95)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure(0.24)Diluted EPS, FY2025, twelve months to 2025-12-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure
Free cash flow$m(23.5)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$13.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-16, accession 0001323885-24-000016.Capital expenditure: $9.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-16, accession 0001323885-24-000016.Report this figure(39.0)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$22.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-14, accession 0001323885-25-000009.Capital expenditure: $16.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-14, accession 0001323885-25-000009.Report this figure(7.5)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001323885-26-000007.Capital expenditure: $12.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure0.7Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001323885-26-000007.Capital expenditure: $11.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure48.3Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $57.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001323885-26-000007.Capital expenditure: $9.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001323885-26-000007.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding AtriCure, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$125.2m4,474,548Added+431,867
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$97.8m3,495,603Added+113,048
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$87.5m3,127,195Added+424,563
Hood River Capital Management LLC2026-06-30$81.3m2,905,299Reduced−212,246
ALLIANCEBERNSTEIN L.P.2026-06-30$79.0m2,768,365Reduced−490,507
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$61.3m2,190,413Added+34,649
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.2026-06-30$48.5m1,734,279Reduced−70,648
GOLDMAN SACHS GROUP INC2026-06-30$44.7m1,597,988Reduced−69,178
STATE STREET CORP2026-06-30$38.9m1,389,989Added+87,827
MARSHALL WACE, LLP2026-06-30$37.3m1,333,904Reduced−133,620

Recent filings

All 1,325 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

AtriCure, Inc., recent filings
FiledFormWhat it isAccession number
2026-07-2717:07 ET10-QQuarterly reportPeriod 2026-06-300001323885-26-000035
2026-07-2320:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001323885-26-000032
2026-05-1920:21 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001323885-26-000025
2026-05-0616:31 ET10-QQuarterly reportPeriod 2026-03-310001323885-26-000023
2026-05-0601:01 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0001323885-26-000020
2026-05-0520:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001323885-26-000018
2026-04-0615:54 ETDEF 14AProxy statementPeriod 2026-04-060001323885-26-000010
2026-02-1917:39 ET10-KAnnual reportPeriod 2025-12-310001323885-26-000007
2026-02-1721:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001323885-26-000005
2026-01-1213:00 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-009814

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 19, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1323885
Tickers
ATRC
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.